Google
 

Article Index
HIV Drug and Treatment
General
- Changing Antiretroviral Therapy: Why, When, and How
- Nutrition and HIV
Fuzeon
- Introduction: Why Do We Need a New Class of HIV Medications?
- Entry Inhibitors: A New Class of HIV Medications
- How Does Fuzeon Work?
- What We Know About Fuzeon
- Who Fuzeon Works Best For
- Fuzeon's Side Effects
- Conclusion: Fuzeon's Role in Treatment
- Ten Tips on Injecting Fuzeon
- FUZEON: avoiding injection-site reactions
Alternative
- Could green tea prevent HIV?
- Ayurvedic Management of HIV/AIDS

News
- Scouts get the HIV message
- Perspectives on Asia Pacific AIDS conference
-
Myanmar: Towards universal access
-
Orphans with HIV/AIDS and Family Health and Wellness Programs to Benefit from Constella's Enhancing Human Health Grants
- Foods debunked as alternatives to AIDS meds
- Thailand HIV/AIDS Situation
- Kenya: HIV Patients Suffer As Drug is Recalled
- Niger's Religious Leaders Form Alliance To Prevent Spread Of HIV
- Morality Gets a Massage
-
An African Solution
- Greytown Hospital Kept Open with Help of Umvoti AIDS Centre Volunteers
- Guangdong faces severe HIV situation
- UN corrects itself, India’s HIV situation isn’t that bad
- New AIDS figures show low prevalence (India)
- The Sydney Declaration: Good Research Drives Good Policy and Programming - A Call to Scale Up Research
- Million more AIDS deaths forecast in South Africa by 2010
- Brazilian President Silva Issues Compulsory License for Merck's Antiretroviral Efavirenz
- FDA Approves First Oral Fluid Based Rapid HIV Test Kit
- HIV/AIDS funding gap could hit 50% by 2007: U.N. agency

Miscellaneaus
- Red ribbon history
- HIV and AIDS in africa
-
Dr Krisana Kraisintu first used her pharmaceutical expertise to make HIV/Aids treatment affordable in Thailand, then she moved on to Africa
- Speech at Harward by Bill Gates
- Quit complain in
- Urban action networks; HIV/AIDS and community organizing in New York City
- Living With HIV

2007/08/31

Papua New Guinea Government Should Expand HIV/AIDS Education Campaigns To Rural Areas

Source : http://www.emaxhealth.com

Some HIV/AIDS advocates in Papua New Guinea have called on the government and aid agencies to extend HIV/AIDS awareness campaigns from cities and towns to rural areas to fight mistreatment of and discrimination against people living with the disease, AFP/Yahoo! News reports. Margaret Marabe, who works with the group Igat Hope, spent five months carrying out an HIV/AIDS education campaign in the country's remote Southern Highlands. She recently told reporters that she saw five people buried alive because they were living with HIV/AIDS (AFP/Yahoo! News, 8/27).

readmore

AIDS victims 'buried alive' in PNG

source : http://news.yahoo.com/

Mon Aug 27, 12:26 PM ET

PORT MORESBY (AFP) - Some AIDS victims are being buried alive in Papua New Guinea by relatives who cannot look after them and fear becoming infected themselves, a health worker said Monday.

Margaret Marabe, who spent five months carrying out an AIDS awareness campaign in the remote Southern Highlands of the South Pacific nation, said she had seen five people buried while still breathing.

One was calling out "Mama, Mama" as the soil was shoveled over his head, said Marabe, who works for a volunteer organisation called Igat Hope, Pidgin English for I've Got Hope.
"One of them was my cousin, who was buried alive," she told reporters.

"I said, 'Why are they doing that?' And they said, 'If we let them live, stay in the same house, eat together and use or share utensils, we will contract the disease and we too might die.'"
Villagers had told her it was common for people to bury AIDS victims alive.

Marabe appealed to the government and aid agencies to ensure the HIV/AIDS awareness programme carried out in cities and towns was extended to the rural areas, where ignorance about the disease is widespread.

Women accused of being witches have been tortured and murdered by mobs holding them responsible for the apparently inexplicable deaths of young people stricken by the epidemic, officials and researchers say.

A recent United Nations report said PNG was facing an AIDS catastrophe, accounting for 90 percent of HIV infections in the Oceania region.

HIV diagnoses had risen by around 30 percent a year since 1997, leaving an estimated 60,000 people living with the disease in 2005.
----------------------------------------------------------------

My comment : I feel so sad about this news. There are still many people all over the world that misunderstood about AIDS. Someone think that if only live with HIV patients, they can be infected by HIV (The truth is HIV can be spread by sexual transmission, by blood, mucous or semen). So this's the tragedy for our world, therefore Education and announcement about AIDS/HIV are such important missions for everyone,also UNAIDS.

2007/08/25

Could green tea prevent HIV?

source : http://www.accessmylibrary.com/

Green tea: fact or fiction

Publication: HIV Treatment: ALERTS!
Publication Date: 06/01/2007
Author: Nance, Christina L.

The Center for AIDS: Hope & Remembrance Project

Scientists have discovered that a substance in green tea prevents HIV from attaching to our immune system cells by getting there first. According to researchers from Baylor College of Medicine in Houston and the University of Sheffield in the England, in a report that appears in the Journal of Allergy and Clinical Immunology (1), a compound in green tea called catechin, (also known as epigallocatechin gallate [EGCG] or flavonoid) blocks the ability of HIV to enter and destroy the immune system.

The health effects of brewed green tea are attributed to numerous chemical substances that make up 30% of dried leaf extract. Of these, EGCG is the most active. Similar substances in other plants have been found to be less plentiful and have fewer medicinal properties. EGCG binds well to many molecules and affects a variety of enzyme. It is this specific aspect of green tea that researchers think is responsible for its many reported health benefits.

Animal studies have shown that drinking green tea is associated with a lower rate of cancer in humans. The major component of green tea, EGCG, is thought to be the most potent cancer-preventive component of the catechins. This protective effect of green tea has been evaluated in pancreatic, colon, rectal, skin, breast, prostate, liver, and lung cancel: Recently EGCG has emerged as a potential candidate in the fight against AIDS. Investigators have found that its antiviral effects can be targeted at HIV infection. However, this does not mean you should start drinking gallons of green tea every day. But, there is some encouraging news.

HIV infection results in damage to the immune system when the gpl20 glycoprotein (a protein that has sugar molecules attached to it) latches onto the T cell. Even though gpl20 produces antibodies that help light against the virus, HIV manages to escape, leading to infection. Ever since the discovery of the virus as the cause of AIDS, there has been an intense effort to develop methods to slow down or prevent HIV infection. Until now, scientists have spent much of their time trying to find ways to build up the immune system to prevent HIV from attaching itself to the T cells. Christina L. Nance, PhD, and William T. Shearer, MD, PhD, of Baylor College of Medicine and Texas Children's Hospital, and Mike R Williamson, PhD, of the University of Sheffield, began looking at ways to get high enough levels of EGCG into the body for it to be able to protect the body against HIV. They paired the T cell with gpl20, then paired the T cell with EGCG. By studying the physical structure of the T cell, they realized that EGCG hooks onto the same exact pocket on the T cell as gp 120. This ability to block gp 120 is its most important feature since it prevents the initial encounter of HIV with T cells.

If EGCG proves to have value as an HIV treatment, it probably will not be used alone. It would be part of a combination of drugs. The researchers do not recommend that people drink large quantities of green tea with the expectation that it will prevent infection with HIV. These studies are designed to determine whether a drug derived from green tea would have that effect. The next phase of the research will be testing EGCGin humans.

(1) Journal of Allergy and Clinical Immunology 118(6): 1369-74, Dec 2006. Christina L. Nance, PhD, is Instructor and Research Laboratory Supervisor at Baylor College of Medicine, Department of Allergy/Immunology, Texas Children's Hospital.

-----------------------------------------------------------------
My comment : It's such a good news that brings much hope for many HIV patients, but I doubt can it works in human. There are also just a few research,so it dosen't mean that patients should drink a gallon of green tea. Instead of drinking green tea as water, they should beware of their health, exercise to be healthy, take off drugs as the practitioner prescribes ontime (Important: don't forget it) and just relax their mind. All of these are much more important to have a good quality of life.

Red ribbon history

source : http://www.worldaidsday.org

Who created the red ribbon?
The red ribbon has been an international symbol of AIDS awareness since 1991. The Red Ribbon Project was created by the New York based organisation Visual AIDS, which brought together artists to create a symbol of support for the growing number of people living with HIV in the US.

What does it symbolise?
The red ribbon is worn as a sign of support for people living with HIV. Wearing a red ribbon is a simple and powerful way to challenge the stigma and prejudice surrounding HIV and AIDS that prevents us from tackling the global epidemic.

Who owns the red ribbon?
The red ribbon is the result of collaboration between community artists who wanted to create a non-copyrighted image that could be used as an awareness-raising tool by people across the world.

When did the red ribbon go international?
The first international celebrity to wear a red ribbon was Jeremy Irons at the 1991 Tony Awards. The symbol came to Europe on a mass scale on Easter Monday in 1992, when more than 100,000 red ribbons were distributed during the Freddie Mercury AIDS Awareness Tribute Concert at Wembley stadium. More than 1 billion people in more than 70 countries worldwide watched the show on television. Throughout the nineties many celebrites wore red ribbons, encouraged by Princess Diana’s high profile support for AIDS.

HIV and AIDS in africa

Source : http://www.avert.org/aafrica.htm - AVERT is an international AIDS charity

Sub-Saharan Africa is more heavily affected by HIV and AIDS than any other region of the world. An estimated 24.5 million people were living with HIV at the end of 2005 and approximately 2.7 million additional people were infected with HIV during that year. In just the past year, the AIDS epidemic in Africa has claimed the lives of an estimated 2 million people in this region. More than twelve million children have been orphaned by AIDS.

The extent of the AIDS crisis is only now becoming clear in many African countries, as increasing numbers of people with HIV are becoming ill. In the absence of massively expanded prevention, treatment and care efforts, it is expected that the AIDS death toll in sub-Saharan Africa will continue to rise. This means that impact of the AIDS epidemic on these societies will be felt most strongly in the course of the next ten years and beyond. Its social and economic consequences are already widely felt, not only in the health sector but also in education, industry, agriculture, transport, human resources and the economy in general.

How are different countries in Africa affected?

Both HIV prevalence rates and the numbers of people dying from AIDS vary greatly between African countries. In Somalia and Senegal the HIV prevalence is under 1% of the adult population, whereas in South Africa and Zambia around 15-20% of adults are infected with HIV.
In four southern African countries, the national adult HIV prevalence rate has risen higher than was thought possible and now exceeds 20%. These countries are Botswana (24.1%), Lesotho (23.2%), Swaziland (33.4%) and Zimbabwe (20.1%).

West Africa has been less affected by AIDS, but the HIV prevalence rates in some countries are creeping up. HIV prevalence is estimated to exceed 5% in Cameroon (5.4%), Côte d'Ivoire (7.1%) and Gabon (7.9%).

Until recently the national HIV prevalence rate has remained relatively low in Nigeria, the most populous country in Sub-Saharan Africa. The rate has grown slowly from below 2% in 1993 to 3.9% in 2005. But some states in Nigeria are already experiencing HIV infection rates as high as those now found in Cameroon. Already around 2.9 million Nigerians are estimated to be living with HIV.

Adult HIV prevalence in East Africa exceeds 6% in Uganda, Kenya and Tanzania.

Trends in Africa's AIDS epidemic

Large variations exist between the patterns of the AIDS epidemic in different countries in Africa. In some places, the HIV prevalence is still growing. In others the HIV prevalence appears to have stabilised and in a few African nations - such as Kenya and Zimbabwe - declines appear to be underway, probably in part due to effective prevention campaigns. Others countries face a growing danger of explosive growth. The sharp rise in HIV prevalence among pregnant women in Cameroon (more than doubling to over 11% among those aged 20-24 between 1998 and 2000) shows how suddenly the epidemic can surge.

Overall, rates of new HIV infections in Sub-Saharan Africa appear to have peaked in the late 1990s, and HIV prevalence seems to be levelling off, albeit at an extremely high level. Stabilisation of HIV prevalence occurs when the rate of new HIV infections is equalled by the AIDS death rate among the infected population. This means that a country with a stable but very high prevalence must be suffering a very high number of AIDS deaths each year. Although prevalence remains stable, the actual number of Africans living with HIV is rising due to general population growth.

What is the effect of these high levels of HIV infection?

Over and above the personal suffering that accompanies HIV infection, the AIDS epidemic in sub-Saharan Africa threatens to devastate whole communities, rolling back decades of development progress.

Sub-Saharan Africa faces a triple challenge of colossal proportions:

Providing health care, support and solidarity to a growing population of people with HIV-related illness, and providing them with treatment.

Reducing the annual toll of new HIV infections by enabling individuals to protect themselves and others.

Coping with the cumulative impact of over 20 million AIDS deaths on orphans and other survivors, on communities, and on national development.

What is the impact of AIDS on Africa?

HIV & AIDS are having a widespread impact on many parts of African society. The points below describe some of the major effects of the AIDS epidemic. For a more detailed examination, visit our African impact page.

In many countries of Sub-Saharan Africa, AIDS is erasing decades of progress made in extending life expectancy. Millions of adults are dying from AIDS while they are still young, or in early middle age. Average life expectancy in Sub-Saharan Africa is now 47 years, when it could have been 62 without AIDS.

The effect of the AIDS epidemic on households can be very severe. Many families are losing their income earners. In other cases, income earners are forced to stay at home to care for relatives who are ill from AIDS. Many of those dying from AIDS have surviving partners who are themselves infected and in need of care. They leave behind orphans, grieving and struggling to survive without a parent's care.

In all affected countries, the HIV/AIDS epidemic is putting strain on the health sector. As the epidemic develops, the demand for care for those living with HIV rises, as does the number of health workers affected.

Schools are heavily affected by HIV/AIDS. This a major concern, because schools can play a vital role in reducing the impact of the epidemic, through education and support.

HIV/AIDS dramatically affects labour, setting back economic activity and social progress. The vast majority of people living with HIV/AIDS in Africa are between the ages of 15 and 49 - in the prime of their working lives. Employers, schools, factories and hospitals have to train other staff to replace those at the workplace who become too ill to work.

Through its impacts on the labour force, households and enterprises, HIV/AIDS can act as a significant brake on economic growth and development. HIV/AIDS is already having a major affect on Africa's economic development, and in turn, this affects Africa's ability to cope with the epidemic.

HIV prevention in Africa

A continued rise in the number of Africans living with HIV and dying from AIDS is not inevitable. There is growing evidence that HIV prevention efforts can be effective, and this includes initiatives in some of the most heavily affected countries.

In some countries there have been early and sustained HIV prevention efforts. For example, effective HIV prevention campaigns have been carried out in Senegal, which is still reflected in the relatively low adult HIV prevalence rate of 0.9%. Also, the experience of Uganda shows that a widespread AIDS epidemic can be brought under control. HIV prevalence in Uganda fell from around 15% in the early 1990s to around 5% by 2001. This change is thought to be largely due to intensive HIV prevention campaigns.

More recently, similar declines have been seen in Kenya, Zimbabwe and urban areas of Zambia and Burkina Faso. However, the extremely severe AIDS epidemics in South Africa, Swaziland and Mozambique continue to grow.

Overall a massive expansion in prevention efforts is needed, and although there is no single or immediate tool to prevent new HIV infections, the major components of a successful HIV prevention programme are now known.

Condom use & HIV
Condoms play a key role in preventing HIV infection around the world. In Sub-Saharan Africa, most countries have seen an increase in condom use in recent years. In studies carried out between 2001 and 2005, eight out of eleven countries in Sub-Saharan Africa reported an increase in condom use.

The distribution of condoms to countries in Sub-Saharan Africa has also increased: in 2004 the number of condoms provided to this region by donors was equivalent to 10 for every man,4 compared to 4.6 for every man in 2001.

In most countries, though, many more condoms are still needed. For instance, in Uganda between 120 and 150 million condoms are required annually, but less than 40 million were provided in 2005.

Relative to the enormity of the HIV/AIDS epidemic in Africa, providing condoms is cheap and cost effective. Even when condoms are available, though, there are still a number of social, cultural and practical factors that may prevent people from using them. In the context of stable partnerships where pregnancy is desired, or where it may be difficult for one partner to suddenly suggest condom use, this option may not be practical.

Provision of Voluntary HIV Counselling & Testing (VCT)
The provision of voluntary HIV counselling and testing (VCT) is an important part of any national prevention program. It is widely recognised that individuals living with HIV who are aware of their status are less likely to transmit HIV infection to others, and that through testing they can be directed to care and support that can help them to stay healthy. VCT also provides benefit for those who test negative, in that their behaviour may change as a result of the test. The provision of VCT has become easier, cheaper and more effective as a result of the introduction of rapid HIV testing, which allows individuals to be tested and find out the results on the same day. VCT could – and indeed needs to be – made more widely available in most Sub-Saharan African countries.

Mother-to-child transmission of HIV
Around 2 million children in Sub-Saharan Africa were living with HIV at the end of 2005. They represent more than 85% of all children living with HIV worldwide.7 The vast majority of these children will have become infected with HIV during pregnancy or through breastfeeding when they are babies, as a result of their mother being HIV-positive.

Mother to child transmission (MTCT) of HIV is not inevitable. Without interventions, there is a 20-45% chance that a HIV-positive mother will pass infection on to her child. If a woman is supplied with antiretroviral drugs, though, this risk can be reduced significantly. Before this measures can be taken the mother must be aware of her HIV-positive status, so testing also plays a vital role in the prevention of MTCT.

In many developed countries, these steps have helped to virtually eliminate MTCT. Yet Sub-Saharan Africa continues to be severely affected by the problem, due to a lack of drugs, services and information. The shortage of testing facilities in many areas is also contributing. Fewer than 6% of pregnant women in Sub-Saharan Africa were offered services to prevent MTCT in 2005.8
Given the scale of the MTCT crisis in Africa, it is remarkable that more is not being done (by both the international community and domestic governments) to prevent the rising numbers of children becoming infected with HIV, and dying from AIDS. AVERT is calling for vast improvements in preventing MTCT strategies through our Stop AIDS in Children campaign. This crisis is discussed in more detail in our PMTCT worldwide page.

HIV/AIDS related treatment and care in Africa

Antiretroviral drugs
Antiretroviral drugs (ARVs) - which significantly delay the progression of HIV to AIDS and allow people living with HIV to live relatively normal, healthy lives – have been available in richer parts of the world since around 1996. Distributing these drugs requires money, a well-structured health system and a sufficient supply of healthcare workers. The majority of developing countries are lacking in these areas and have struggled to cope with the increasing numbers of people requiring treatment.

For most Africans living with HIV, ARVs are still not available - fewer than one in five of the millions of Africans in need of the treatment are receiving it. Many millions are not even receiving treatment for opportunistic infections, which affect individuals whose immune systems have been weakened by HIV infection. These facts reflect the world’s continuing failure, despite the progress of recent years, to mount a response that matches the scale and severity of the global HIV/AIDS epidemic.

Botswana pioneered the provision of ARVs in Africa, starting its national treatment programme in January 2002. By 2005 this programme was providing treatment to the vast majority of those in need. According to World Health Organisation figures, 84,000 people were receiving treatment at the end of 2006, including those using the private sector, giving a coverage rate above 95%.9 Thousands of lives have been saved as a result.

While most African countries have now started to distribute ARVs, progress in providing sufficient quantities of the drugs has been uneven and Botswana’s success has not been emulated elsewhere. Among the other countries that have made advances are Rwanda and Namibia, where more than 70% of people in need of ARVs are receiving them. In Cameroon, Côte d’Ivoire, Kenya, Malawi and Zambia, between 25% and 45% of people requiring antiretroviral drugs were receiving them in December 2006. While South Africa is the richest nation in Sub-Saharan Africa and should have led the way in ARV distribution, its government was slow to act; so far, only 33% of those in need of treatment in South Africa are receiving it. In other countries, such as Ghana, Mozambique, Nigeria, the United Republic of Tanzania and Zimbabwe, the figure is less than 20%.

Nonetheless, the overall situation is slowly improving; the number of people receiving ARVs in Africa doubled in 2005 alone.11 International support has helped this increase, with numerous governments and international organisations encouraging progress. In 2003 the World Health Organisation (WHO) initiated the ‘3 by 5’ programme, which aimed to have three million people in developing countries on ARVs by the end of 2005. While this target was not reached, a number of African nations made substantial progress under the scheme. The latest international target, ‘All by 2010’, is aiming at universal access to treatment by 2010. In pursuit of this goal it is hoped that considerable progress will be made in Africa's fight against AIDS.

There are still, however, a number of impediments to ARV provision. One major challenge is the fact that the majority of African countries have a poor healthcare infrastructure and a shortage of medical professionals. A considerable emphasis needs to placed not only on the availability of ARVs, but also the availability of professionals who are able to administer the drugs.

Another major challenge is ensuring that drugs are not only supplied to a lot of areas, but that sufficient quantities of drugs are supplied to those areas. This is critically important, because once an individual starts to take ARVs they have to take them for the rest of their life. If, for instance, their local hospital runs out of ARVs, the interruption that this causes in their treatment could result in them becoming resistant to the drugs. To improving treatment programs, African countries face the double challenge of getting new people to start treatment and maintaining the supply of treatment to those who are already receiving ARVs.

Other forms of treatment and care
Treatment and care for HIV consists of a number of different elements apart from ARVs. These include voluntary counselling and testing, food and management of nutritional effects, follow-up counselling, protection from stigma and discrimination, treatment of other sexually transmitted infections, and the prevention and treatment of opportunistic infections. All of these things can, and indeed should, be provided before ARVs are available. This does not exclude the provision of ARVs when they are available. Indeed, when ARVs do become available the provision of antiretroviral therapy should be easier and quicker to implement because many of the things apart from drugs that are needed for successful treatment are already in place.

What needs to be done to make a difference in Africa?

International support
One of the most important ways in which the situation in Africa can be improved is through increased funding. More money would help to improve both prevention campaigns and the provision of treatment and care for those living with HIV. Developed countries have increased funding for the fight against AIDS in Africa in recent years, perhaps most significantly through the Global Fund to fight AIDS, Tuberculosis and Malaria. The Global Fund was started in 2001 to co-ordinate international funding and has since approved grants totalling US $3.3 billion to fight HIV and AIDS in Africa. Around 60% of the fund’s grants have been directed towards Africa and 60% has been put towards fighting AIDS. This funding is making a significant difference, but given the massive scale of the AIDS epidemic more money is still needed.

The US Government has shown a commitment to fighting AIDS in Africa through the President’s Emergency Plan For AIDS Relief (PEPFAR). Started in 2003, PEPFAR provides money to fight AIDS in numerous countries, including 15 focus countries, most of which are African. In Fiscal Year 2005, PEPFAR allocated US $1.1 billion to these African focus countries.14 The US Government is also the largest contributor to the Global Fund.

Among other things, organisations like PEPFAR and the Global Fund provide vital support to local and community groups that are working 'on the ground' to provide relief in Africa. These groups are directly helping people in need, and many rely on international funding in order to operate. Getting money from large, international donors to small, 'grassroots organisations' can present a number of difficulties though, as money is lost or delayed as it is passed down large funding chains. Our page about getting money to local organisations discusses these issues, and the work that such groups do.

Domestic commitment
More than money is needed if HIV prevention and treatment programmes are to be scaled up in Africa. In order to implement such programmes, a country’s health, education, communications and other infrastructures must be sufficiently developed. In some African countries these systems are already under strain and are at risk of collapsing as a result of AIDS. Money can also only be used efficiently if there are sufficient human resources available, but there is an acute shortage of trained personnel in many parts of Africa.

In many cases, African countries also need more commitment from their governments. There are promising signs that some governments are starting to respond and becoming more involved in the fight against AIDS, and this commitment needs to be sustained if the severe impact of Africa's AIDS pandemic is to be reduced.

Reducing stigma and discrimination
HIV-related stigma and discrimination remains an enormous barrier to the fight against AIDS. Fear of discrimination often prevents people from getting tested, seeking treatment and admitting their HIV status publicly. Since laws and policies alone cannot reverse the stigma that surrounds HIV infection, more and better AIDS education is needed in Africa to combat the ignorance that causes people to discriminate. The fear and prejudice that lies at the core of HIV/AIDS discrimination needs to be tackled at both community and national levels.

Helping women and girls
In many parts of Africa, as elsewhere in the world, the AIDS epidemic is aggravated by social and economic inequalities between men and women. Women and girls commonly face discrimination in terms of access to education, employment, credit, health care, land and inheritance. These factors can all put women in a position where they are particularly vulnerable to HIV infection. In Sub-Saharan Africa, around 59% of those living with HIV are female.

In many African countries, sexual relationships are dominated by men, meaning that women cannot always practice safe sex even when they know the risks involved. Attempts are currently being made to develop a microbicide – a cream or gel that can be applied to the vagina, preventing HIV infection – which could be a significant breakthrough in protecting women against HIV. Women could apply such a microbicide without their partner even knowing. It is likely to be some time before a microbicide is ready for use, though, and even when it is, women will only use it if they have an awareness and understanding of HIV and AIDS. To promote this, a greater emphasis needs to be placed on educating women and girls about AIDS, and adapting education systems (which are currently male-dominated) to their needs.

The way forward
Tackling the AIDS crisis in Africa is a long-term task that requires sustained effort and planning - both within African countries themselves and amongst the international community. One of the most important elements of the fight against AIDS is the prevention of new HIV infections. HIV prevention campaigns that have been successful within African countries need to be highlighted and repeated.

The other main challenge is providing treatment and care to those living with HIV in Africa, in particular ARVs, which can allow people living with HIV to live long and healthy lives. Many African countries have made significant progress in their treatment programmes in recent years and it is likely that the next few years will see many more people receiving the drugs.

Scouts get the HIV message

source : http://www.unaids.org/

16 August 2007

As part of the international scout jamboree held in Britain over the summer, UNAIDS ran workshops on HIV prevention, personal responsibility in HIV transmission and respect for the human rights of positive people.

This summer, residents of Chelmsford, a town in eastern England, woke up to an unusual array of sights and sounds.

The banging of early morning drums and excited screeches of hundreds of teenage boys and girls filled the air – this was the international scout jamboree, and the 40,000 teenagers attending from all over the world wanted to make sure everyone knew it!

For UNAIDS staff attending the jamboree to run special workshops on HIV prevention, personal responsibility in HIV transmission and respect for the human rights of positive people, it was a bit of an eye opener. “We would look at each other and think: ‘Are you as lost as I am?’ ” laughs Bhatupe Mhango, coordinator of UN Plus – the UN system-wide group of staff living with HIV, who took part in the event with Alex McLelland, an intern with UNAIDS, in the Civil Society Partnerships Unit. “But we became hooked on those sessions every morning. I still hear them drumming and humming in my ears,” she says.

This was a particularly significant jamboree, as it marked the centenary of scouting and 40,000 teenagers attended from all over the world. UNAIDS had an area in the Global Development Village, a section dedicated to workshops on human rights and the work of UN agencies.
“The scouts as a movement has so much potential to mobilize towards the HIV response,” says Alex, who is studying for a degree in International Development at York University in Toronto, Canada . “They are eager to get further engaged. With approximately 28 million young people as members you can see the possibilities.”

Bhatupe and Alex planned and ran five workshops on the topic “HIV Sensitisation and Safeguarding Human Rights.” One of the UNAIDS objectives was to initiate a dialogue on the need for a policy to work with HIV positive scouts, and for UN Plus to look for possible partnerships.

“We established that there are some Positive scouts in several countries, particularly Africa, and UN Plus could foster a partnership with them,” says Bhatupe.

Over three days, he and Bhatupe spoke to youngsters from Norway , Germany, Italy, Chile, Brazil, Denmark, Britain, Turkey and Finland.

In spite of the big subject, it was all very informal. “Most of the workshops took place outside because the young scouts wanted to lie on the grass,” says Bhatupe. She and Alex shared their personal stories as people living with HIV. Scouts asked questions about stigma, treatment, nutrition guidelines and human rights issues for people living with HIV.

Bhatupe also did a live radio interview with the jamboree radio station, to promote the workshops and encourage scouts to be aware of the means of protecting themselves from HIV transmission.

There were the obvious drawbacks of talking about sex to teenage boys: “A memorable moment was watching young, Italian boys laughing hysterically at a UNFPA-led workshop we participated in, demonstrating male condoms using bananas,” says Bhatupe.

But many of the scouts showed real insight and understanding into the issue – Alex and Bhatupe were delighted by a group of 14-16 year old girls from Chile, who were well informed about HIV, AIDS and sex, having studied the subject at school. The girls held a debate on abstinence versus early sex.

“The maturity of the debate convinced me that the message on HIV prevention and empowerment of young girls is getting across,” says Bhatupe.

The girls were evenly divided - indicating that no one method is the obvious solution to managing yourself as a young woman in a relationship.
The views expressed included:

“If I love my boyfriend and I trust him…and if he has gone for an HIV test and tells me he is HIV negative, why should I not express my feelings for him and have sex with him? If that is what I want to do, I will just go ahead…if you love someone, you can not put controls on what you can do with that person.”

“For me I say no. I have to wait until I am married before I have sex. It is scary. I am scared of getting HIV or falling pregnant so the best thing to do is to wait.”

For Bhatupe and Alex, the UNAIDS messages were getting across: prevention, personal responsibility in HIV transmission, the need for more support and less stigma for positive people.

Alex was encouraged to see so much focus on AIDS at the jamboree.
“There were other workshops from UNFPA, UNICEF, UNESCO, as well as the South African and Ugandan Scout associations. The Girl Guides did a big presentation about HIV. The ILO discussed child labour and vulnerability to HIV.

“There’s a quite a lot of awareness among the Scouts. It was gratifying to see so much going on,” he said.

Perspectives on Asia Pacific AIDS conference

Source : http://www.unaids.org

17 August 2007

The eighth International Congress on AIDS in Asia and the Pacific (ICAAP) takes place in Colombo, Sri Lanka from 19-23 August 2007. In the run up to the event, UNAIDS Deputy Executive Director, Deborah Landey and UNAIDS Regional Director for Asia and the Pacific, Prasada Rao, share their hopes and expectations for the conference that will host an expected 3,000 participants from some 60 countries throughout the region.

Visions for ICAAP8: Deborah Landey, UNAIDS Deputy Executive Director

Why is this conference important?
I think this conference is extremely important for the world and it’s very important for Asia. Many of the countries in Asia and the Pacific have relatively low prevalence and it’s an opportunity for us to take stock of what’s happening in the region and to come out with the goal of keeping Asia a low prevalence area of the world in terms of AIDS.

What are the focus areas for UNAIDS at this conference?
We are very concerned to emphasize the importance of leadership in responding to the epidemic at all levels—from governments to civil society, all players, actors must be involved.
It’s absolutely vital for countries to ‘know their epidemics’ – and by this we mean really having the most recent, developed data on what is going on with the epidemic in order to be able to use relatively scare resources effectively. In particular we are interested in understanding what we call the ‘drivers of the epidemic’ – the underlying systemic issues such as gender inequality, stigma and discrimination—and getting at these issues so that countries can make fundamental changes to get ahead of their epidemics.

We also want to emphasise that AIDS is going to be with us for a long time to come and therefore the long term agenda and all the issues we need to be thinking about for future generations are extremely important for us to consider here at this meeting.

What can this conference achieve?
If we can get a good analysis and understand what is happening in the region in terms of the epidemic so that we ‘know’ this epidemic in the region, what would be one outstanding outcome. Secondly – we want to know what is happening on the ground, what is working and what is not working? What are the lessons learned, where are we having successes and how can they be replicated? Establishing where the major challenges are will also be a goal.

Visions of Colombo: Prasada Rao, UNAIDS Asia Pacific Regional Director

What’s make the 8 th ICAAP an important meeting?
ICAAP has always been the rallying point for stakeholders such as civil society, people living with HIV, experts, national programme managers, UN partners and donors to focus world’s attention on the special problems of this large region which is home to the 60% of world population. AIDS need to be understood in this specific Asia Pacific context and ICAAP has always provided the best platform for it.

What are the most important issues that are going to be raised and discussed at ICAAP this year?
This ICAAP will specially address the changing AIDS scenario in the region. Recent revision of numbers in some countries has led to a great deal of public and media attention and this is an opportunity to look at the issues squarely and give clarifications. ICAAP will also look at some controversial issues of the moment, such as condom promotion, sex education at school and voluntary testing and counseling, within the Asian context. There will also be clear message about universal access to prevention, treatment, care and support and the need for increased provision of second generation antiretroviral drugs. The Conference also provides a platform for launching two important regional networks of men who have sex with men and sex workers.

What can you tell us about the AIDS epidemic in this region?
The AIDS epidemic in Asia and the Pacific is still increasing and there were approximately 1 million new infections in the last 2 years. Country like Papua New Guinea, Viet Nam Indonesia, Bangladesh and Pakistan are showing an increasing trends of new infections. However, there is good news in some countries. In addition to from Thailand and Cambodia we are seeing a reversal of the epidemic in the southern part of India which has a large population at risk. Infection has remained low in countries like Philippines and Sri Lanka despite large movement of workers for employment outside these countries.

How are countries of Asia and the Pacific scaling up towards universal access to HIV prevention, treatment, care and support?
The universal access agenda has given a great push to the effort of the countries in this region. Based on the political resolution on universal access adopted in UN in June 2007, countries in this region have initiated grassroots planning for setting ambitious target for prevention and treatment. Civil society groups have also enthusiastically participated in this exercise. Today, as many as 16 countries have set universal access targets and nine have prepared national strategic plans and identify resources for implementing them. Asia and the Pacific region can set high standard of achievement for the universal access process.

Myanmar: Towards universal access

source : http://www.unaids.org

21 August 2007 What will it take to reach universal access to HIV prevention, treatment, care and support in Myanmar ? This was the central discussion of a satellite meeting held as part of the 8 th International Congress on AIDS in Asia and the Pacific (ICAAP) on Monday 20 August.
Over the past year the response to AIDS in Myanmar achieved significant progress: a new National Strategic Plan was developed, including the completion of the costed Operational Plan; and in late 2006 the 3-Diseases Fund was launched and became operational in early 2007. “With these key developments, in 2007 there is a real and tangible opportunity to continue to expand the AIDS response in Myanmar with the aim of reaching universal access,” said UNAIDS Country Coordinator, Brain Williams.

Organized by the United Nations Theme Group on AIDS in Myanmar, the satellite session presented an overview of the current epidemic situation; outlined recent gains in the response to AIDS in Myanmar; and highlighted the needs for, and opportunity to, support a further expansion of the response.

Myanmar ’s Deputy Minister of Health Prof. Mya Oo highlighted the country’s commitment to respond to AIDS and outlined efforts underway including the production of a multi-sectoral National Strategic Plan emphasizing reaching out to people most at risk. The Deputy Minister thanked the Three Diseases Fund for their investment in HIV care and prevention services in Myanmar and called for increased resources to be made available to Myanmar to fully enable the response to expand and succeed.

The second keynote speaker, representative of people living with HIV Ms. Naw She Wah, spoke of the needs of people living with HIV to have access to treatment, the need for self-help groups to have expanded support including official recognition from the authorities, and called on international organizations to increase their financing to expand coverage beyond the mere 10% of HIV positive people in need of treatment who are currently receiving it.

Technical presentations were made by the National AIDS Programme Manager Dr. Min Thwe, Dr Wiwat Peerapatanapokin an epidemiologist from the East-West Center and recently participated in an HIV prevalence workshop in Myanmar, and Dr. Frank Smithius , Country Representative, Médecins Sans Frontières Holland (AZG), Myanmar.

“The session underscored the progress that has been made over recent years in Myanmar in demonstrating that services can be delivered to people in need, but highlighted that low coverage requires increased financial support from international and domestic sources in order to achieve Universal Access,” Brian Williams said.

Living With HIV

Source : http://www.unaids.org/

Almost 40 million men, women and children are living with HIV today. People living with HIV often understand each other's situation better than anyone else and are well placed to educate, counsel and advise one another. Around the world, wherever HIV is present, people living with HIV have established support and advocacy groups and networks. Increasingly, members of these groups are called on participate in decision and policy making forums.

Since AIDS emerged, people living with HIV have been a key driving force in the AIDS response and few of the advances made in the last 25 years would have happened without the tremendous efforts, expertise and advocacy of people living with HIV and affected communities. With appropriate support, people living with HIV can and must take a central role in their own country, region, or locality in the direction and delivery of AIDS programmes. Their involvement gives personal power and immediacy to AIDS efforts, improves the relevance of programmes and inspires others into action.

Today the principle of greater and meaningful involvement of people living with HIV is central to many interventions worldwide, People living with HIV are involved in a wide variety of activities at all levels of the AIDS response; from sharing their personal stories and supporting others locally through counseling and treatment literacy initiatives to participating in major global decision and policy-making activities.

Yet there is still much to be done to maximize the participation of people living with HIV in the AIDS response. One crucial aspect is the need to build the capacity of organizations and networks of people living with HIV and ensure their sustainable funding. This is essential if they are to participate fully in the response and properly represent the needs of their constituencies. Capacity building can include assistance for strategic planning and to build organizational, managerial, programmatic, communications and financial expertise within the organization.
Tackling the stigma and discrimination experienced by many people living with HIV and affected communities is also fundamental to creating the kind of environment where people living with HIV can contribute in a meaningful way.

People living have been at the forefront of advocating for universal access to treatment. Ensuring people living with HIV have universal access to treatment, along with appropriate prevention and care services, must go hand with the efforts described above.

Orphans with HIV/AIDS and Family Health and Wellness Programs to Benefit from Constella's Enhancing Human Health Grants

Source : http://findarticles.com
Business Wire, July 30, 2007

DURHAM, N.C. -- Constella Group, a leading global provider of professional health services, announced that it has awarded $20,000 to four organizations to improve the lives of orphans living with HIV/AIDS, to reduce stigma and discrimination associated with HIV and sexually transmitted diseases, to promote health and wellness programs for families, and to improve overall health and well-being of children.

"Through our corporate philanthropy program, we encourage employee volunteerism by awarding Enhancing Human Health grants to organizations where employees actively volunteer," said Donald A. Holzworth, Constella Group chairman and CEO. "We are proud to support organizations dedicated to improving the health and lives of children, individuals and families. The important work of each organization and its members exemplifies volunteerism at its best and advances Constella's vision of enhancing human health around the world, every day."

Constella awarded $7,500 to Reaching a Generation, Inc. (RaG-ZA), a non-profit charitable organization headquartered in South Africa, which strives to empower communities to provide relief care for HIV/AIDS orphans, HIV/AIDS prevention education for children and life-skills training for educators across South Africa. Constella's grant will enable RaG-US to extend its existing website services, to create new collateral fundraising materials and to further develop a child sponsorship program in the United States.

Constella awarded $5,000 to the Decatur Education Foundation, a not-for-profit organization that nurtures and supports academic achievement and enrichment opportunities for children in Decatur, Georgia. The grant will support "Strength and Conditioning," a wellness program for selected adolescents, who are either overweight, at risk of becoming overweight or struggle with poor self-image. The program will offer fitness coaching to encourage physical activity and healthy eating habits.

Constella awarded $5,000 to the Blue Diamond Society (BDS), an organization in Nepal that supports and protects the rights of sexual minority (lesbian, gay, bisexual, transgender) communities. Its mission is to create societal acceptance of sexual minorities; to reduce stigma, discrimination, violence and brutality against sexual minorities; to reduce high-risk sexual behaviors and to encourage the use of Sexually Transmitted Infections (STI) services among sexual minorities to prevent STI/HIV infection. The organization also provides care and support for those sexual minorities who are HIV positive. BDS will use the grant to support its HIV/STD prevention and medical services.

The Foundation for the University of North Carolina at Asheville (UNCA), awarded $2,500, offers a health and wellness program designed and facilitated by students enrolled in the health and wellness undergraduate curriculum. Getting Into Fitness Together (GIFT) is a program for families struggling with weight or fitness issues. Participants engage in physical activity and receive mentoring and incentives for healthy habits. GIFT 2007 families represented multiple minority groups where there is an increased likelihood of obesity and obesity-related disease. Constella will enable expansion of the program by covering the cost of equipment, supplies and incentives. The funding will also allow an honorarium for a student intern to assist in directing the program.

"On behalf of Nepalese sexual minority communities, Blue Diamond Society would like to express our gratitude to Constella Group for this grant," said Sunil Pant, president of BDS. "This support is much needed during what is a crucial time in Nepal for HIV/STD related services. We are also very proud of our friend Philippa Lawson (a Constella Group employee) for her long-term voluntary support which has been, and will be, extremely valuable and important to our struggle for justice and health services needed for sexual minority communities in Nepal."

About Constella Group's Corporate Philanthropy Program
In 2006, Constella established its Corporate Philanthropy Program to support non-profit organizations across the world that share the company's goal toward achieving a healthy and disease-free world. The program encourages employee volunteerism and community service by limiting Enhancing Human Health Grants only to organizations where employees actively volunteer. Under the leadership of its corporate philanthropy officer, Constella established a company-wide representative committee responsible for reviewing grant applications and deciding which grants, and at what amount, Constella should fund. For more information on Constella's Corporate Philanthropy Program contact Jesse Milan, corporate philanthropy officer, at 202.777.0945 or at jmilan@constellagroup.com

About Constella Group
Constella Group is a leading provider of professional health services worldwide, dedicated to enhancing human health around the world, every day. Through its work in health sciences, international development, and pharmaceutical product development, Constella creates and provides health intelligence to help industry and government clients identify and solve critical problems affecting human health. The company's 1,500 employees serve clients from company headquarters in Durham, N.C., from U.S. offices in Research Triangle Park, N.C.; Washington, D.C; Rockville and Frederick, Md.; Glastonbury, Conn.; Atlanta; and Morgantown, W.Va., from U.K.-based offices in Bath, Oxford and Cambridge; from offices in Cologne, Germany; Paris, France; and New Delhi, India; and from client sites and other offices across the world. For more information, visit http://www.constellagroup.com/.

COPYRIGHT 2007 Business WireCOPYRIGHT 2007 Gale Group

Urban action networks; HIV/AIDS and community organizing in New York City

Source : http://findarticles.com
SciTech Book News, March, 2007

Yesterday I found a news about an interesting book. Let's see!

Urban action networks; HIV/AIDS and community organizing in New York City.
Lune, Howard.
Rowman & Littlefield
2007
229 pages
$24.95
Paperback
RA643
In 1994, the AIDS community targeted then-New York mayor Giuliani's threat to close the city's largest service organization for this population. Lune (sociology, William Paterson U. of New Jersey) presents his ethnographic studies of this and other informal HIV/AIDS action networks in theoretical, historical, political, and organizational contexts, and argues for a multi-organizational approach to research on such informal networks and contentious politics. A summary table lists the participating organizations.

HIV/AIDS funding gap could hit 50% by 2007: U.N. agency

source : http://findarticles.com/
Asian Economic News, July 19, 2004

BANGKOK, July 12 Kyodo

Despite a sharp increase in global funding in fighting against HIV/AIDS in the recent years, global funding would still face a 50 percent shortfall by 2007, a U.N. agency predicted Monday.

For an adequate response to the HIV/AIDS epidemic, UNAIDS said in the report ''Financing the Expanded Response to AIDS,'' an estimated $12 billion in global funding will be needed annually by 2005 and $20 billion by 2007.

But the agency projects the availability of only $8 billion for 2005 and $10 billion for 2007, based on funding trends over the past three years and future funding commitments.

''The gap will go from 25 percent (this year) to 50 percent (in 2007),'' Paul De Lay, UNAIDS's director of evaluation, told reporters at the weeklong 15th International AIDS Conference, which began Sunday in Bangkok.

''Probably the most challenging area is how much major donors say they're going to spend in the future,'' he said.

The report noted that most of the funding will still need to come from external donors rather than domestic spending, noting that worst-affected countries of Asia and sub-Saharan Africa rely on funds from international donors to meet most of their needs.

Of the $20 billion needed in 2007, $8.6 billion will be needed in sub-Saharan Africa, $5.6 billion in Asia and $3.4 in Latin America and the Caribbean, and the rest elsewhere.

Included in the $20 billion estimate is $10 billion for prevention services, $7 billion for care and treatment, $2 billion for orphan support, and $1 billion for policy, advocacy and administration.

Despite this year's $6 billion in global funding, most people in poor and middle-income countries still do not have access to AIDS prevention and care services.

According to a report on coverage on HIV/AIDS service in 2003 by the Joint U.N. Program on HIV/AIDS, only 3 percent of all pregnant women in 73 affected countries received drugs to prevent HIV transmission to their babies.

In addition, only 3.6 percent of injecting drug users had access to harm-reduction services while only some 6.9 billion condoms were used worldwide compared with the estimated 12 billion condoms needed for effective HIV prevention, the report said.

AIDS education in primary schools only reached 10 percent of Asian students last year compared with 60 percent in Africa, Eastern Europe and Latin America, according to John Stover, vice president of research organization Future Group International.

''The services that are available are usually located in capital cities...not in the rural areas,'' Stover told the same press conference.

COPYRIGHT 2004 Kyodo News International, Inc.COPYRIGHT 2004 Gale Group

-----------------------------------------------
My comment : I say "Now is year 2007. What's going on about the fund?

2007/08/24

FUZEON: avoiding injection-site reactions

source : http://findarticles.com

AIDS Treatment News, Nov-Dec, 2006

On January 31 the FDA announced that the FUZEON (enfuvirtide) package insert had been changed to include precautions to avoid injection-site reactions, either using a needle, or the Biojector(r) 2000 needlefree injection system. For example, here is one place where changes were made (this is from the new version):

"Patients and caregivers should be instructed on the preferred anatomical sites for administration (upper arm, abdomen, anterior thigh). FUZEON should not be injected near any anatomical areas where large nerves course close to the skin, such as near the elbow, knee, groin or the inferior of medial sections of the buttocks, skin abnormalities, including directly over a blood vessel, into moles, scar tissue, bruises, of near the navel, surgical scars, tattoos or bum sites."

Foods debunked as alternatives to AIDS meds

source : http://www.msnbc.msn.com/id/20394521/

Study disputes S. African official’s claims that garlic, lemon can replace pills

Updated: 3:53 p.m. ET Aug. 22, 2007

CAPE TOWN, South Africa - A study by South African scientists said Wednesday there was no evidence that foods such as garlic and beetroot were a substitute for AIDS medicine, disputing claims by the country’s health minister.

The report — confirming what experts worldwide have said — was likely to increase pressure on the minister, who has been ridiculed for promoting olive oil, garlic, lemon and the African potato for people with AIDS and for questioning the effectiveness of anti-retroviral drugs.

Health Minister Manto Tshabalala-Msimang is also under fire because of the dismissal of her deputy and over newspaper allegations her liver transplant may have been needed because of alcohol abuse. Recent news reports also said she was banned from Botswana for 10 years in the 1970s after being accused of theft at a hospital.

“The panel has concluded that no food, no component made from food, and no food supplement has been identified in any credible study as an effective alternative to appropriate medication,” said professor Barry Mendelow, one of the authors of the 300-page study by the Academy of Science of South Africa.

Nutrition can help
The 15-member panel said healthy eating does appear to help slow the progression of AIDS and tuberculosis. But it cautioned that there was little reliable evidence about the influence of nutrition on the diseases.

"This contrasts dramatically with the huge cloud of often acrimonious controversy that hangs over the subject and has become a source of widespread concern in, and about, the government, both within and outside the country,” the panel said.

Tshabalala-Msimang’s spokesman could not be reached for comment on the report.
Controversy about the country’s AIDS policy has raged for years, with critics accusing the government of doing too little to slow the epidemic, which affects an estimated 5.4 million South Africans. An estimated 900 people die each day of the disease in South Africa, and some 1,400 are newly infected. A report last year warned that only half the 15-year-olds now alive would live to celebrate their 60th birthdays.

readmore : http://www.msnbc.msn.com/id/20394521/

Thailand HIV/AIDS Situation

Source: UNAIDS - http://www.un.or.th

Country Situation Analysis

Thailand is known for its success in fighting HIV/AIDS, one of a very few countries in the world that has managed to reverse the spread of the epidemic. However, the challenge now is to ensure that this success does not lead to complacency and inaction. The prevalence of the disease is still relatively high, affecting many lives, and Thailand is still vulnerable to a resurgence of a generalized epidemic. If Thailand falters in its effort to control the disease, the impact would be far-reaching, dealing a major blow to the global response to HIV/AIDS, to UNAIDS, and to the many countries of the world struggling to follow Thailand’s example, bringing into question the effectiveness of the prevention-based paradigm.

Achievements

Thailand has achieved a stunning 83 per cent reduction in new infections, dropping from the 1991 peak of 142,819 new infections per year to an estimated 21,260 in 2003.

An early multi-sector response involving several key ministries, municipalities, NGOs, media, communities, private sector, and the police, focused largely on risk reduction in commercial sex, has enabled Thailand to achieve this turn-around in HIV infections.

Strong political commitment in the early 1990s and the formation of the National AIDS Prevention and Control Committee under the Office of the Prime Minister and PM’s own chairing of NAPCC (National AIDS prevention and Control Committee) ensuring participation of all ministry supported by a comprehensive multi-ministerial plan by the NESDB (National Economic and Social Development Board)

Financing for HIV/AIDS reaching 89.85 million US dollar in 1996 (per capita investment of 1.32 USD) of which 91.2% came from Royal Thai Government (RTG).

Overall, three factors contributed to reducing sexual transmission of the HIV virus: reducing brothel visits, condom compliance, and improved STI control through the introduction of powerful antibiotics, thereby reducing risk of HIV infection.

2007/08/22

Kenya: HIV Patients Suffer As Drug is Recalled

source: http://allafrica.com/

The Nation (Nairobi)
9 August 2007Posted to the web 9 August 2007

Caroline WafulaNairobi

Several Aids patients have had to switch to alternative medicine following the recall of a key anti-retroviral drug from the market.

Viracept, an ARV agent for use in HIV therapy, was withdrawn from the European Union market in June by Swiss pharmaceutical company Roche after it was found to be contaminated with cancer-causing by-products.

Patients taking the drug started complaining in May that it was emitting a strange smell and a subsequent analysis revealed impurities with higher-than-normal levels of methane sulfonic acid ethyl, a substance that can damage DNA and may generate cancer.
Mr William Burns, the chief executive officer of Roche's pharmaceutical division, said the contamination had been caused by the interaction of two chemicals in a vessel where the drug is produced.

Generic name
In Kenya, a total of 7,152 packs of the drug have been collected from various batches, including those already collected by patients. They are to be destroyed.
Viracept, a second-line HIV and Aids drug, is authorised for the treatment of infected adults and children.

The drug, whose generic name is Nelfinavir, is considered to be an important defence against HIV and is used by patients who don't respond to first-line drugs or suffer side effects and also in the prevention of mother-to-child transmission.
The recall has left patients with the painful choice of discontinuing the life-saving medicine or switching to expensive options, which many cannot afford.

Free of charge
In Kenya, most patients get the drug free of charge under President Bush's Emergency Plan for Aids Relief.

Dr Antony Wanyoike, Roche's regional manager, said the affected packs were worth Sh44 million and that between 800 and 900 patients were using the drug.

He told the Nation that the company had managed to recall 99 per cent of the affected batches. "We have all the 7,152 packs in quarantine in our warehouse and we are waiting to have them destroyed," he said.

No complaint
The official added that no complaints had been reported from Kenyan patients.

In the courts, a man was yesterday charged with unlawfully importing drugs and Part 1 poisons.
Mr Anthony Kibe Gitau denied that last July 31, at Jomo Kenyatta International Airport, he was found to have unlawfully imported 45,000 tablets of Metakelfin. He was released on a cash bail of Sh300,000.

Additional reporting: Jonathan Konuche

2007/08/11

Morality Gets a Massage

Source: The Nation - http://www.thenation.com

editorial posted May 10, 2007 (May 28, 2007 issue)

So far, the most significant player to show up on Washington madam Deborah Jeane Palfrey's much-discussed client list is USAID chief Randall Tobias, the former pharmaceutical company CEO who ran Bush's global AIDS initiative for its first three years. His ignominious tenure as AIDS ambassador was marked by a preference for pricey brand-name HIV drugs over cheap generics, which sharply reduced the number of people who could be treated. Ironically, given his regular "massages" from call girls, when we can surmise he ignored the abstinence-only instruction to "keep all of your clothes all the way on all of the time," Tobias was also an avid defender of the President's puritanical approach to HIV prevention.

Tobias was the hatchet man who forced every US grant recipient to publicly condemn prostitution--even struggling outfits doing the sensitive work of persuading destitute sex workers to use condoms. A forthcoming study from the Center for Health and Gender Equity of five Asian countries where commercial sex is driving the AIDS epidemic found that the policy has resulted in the closure of drop-in centers for street prostitutes and a scaling back of other successful prevention efforts.

It was Tom DeLay's ethically challenged Congress that slapped the global AIDS initiative with a one-third abstinence earmark on prevention. Tobias promoted this approach so zealously that in some countries, like Nigeria, nearly 70 percent of all US dollars granted to prevent the sexual transmission of HIV were channeled toward abstinence.

Tobias is not the first abstinence czar to leave his job after running afoul of the moral agenda he promoted. Claude Allen, once the leading White House abstinence advocate, stepped down as domestic policy adviser last year after he was caught stealing. Ted Haggard, once head of the National Association of Evangelicals--powerful boosters of abstinence-only spending--resigned last fall after a gay hustler named him as a client. But Tobias's fall comes as momentum is finally building against the $2.5 billion-and-counting abstinence boondoggle.

Though the Institute of Medicine called for the elimination of abstinence-only programs in 2000, Bush set about doubling their budget instead. Last month the Administration's own study--mandated by Congress a decade ago but delayed while ideological spinmeisters handicapped the criteria to help produce favorable results--was finally released. Posted quietly on the web without even a press release, it affirmed what every academic study had found before: Preaching abstinence doesn't produce it. Numerous studies show that contraceptive access cuts teen pregnancy rates and condom education dramatically reduces HIV transmission.
As with opposition to the war, the American people are ahead of Congress on this issue. A recent study found that 82 percent of Americans want comprehensive sex education for their kids. Nine states have now turned down the tempting pot of abstinence money, including "red state" Montana. Abstinence funding should go the way of Randall Tobias. Legislation like the Pathway Act, which would revoke the abstinence earmark on global AIDS spending, and the Real Act, which would allocate funds for comprehensive sex ed, both introduced by Barbara Lee, need muscle from Democratic leaders. When the President's AIDS initiative comes up for reauthorization in two years, Congress should strike the prostitution pledge and the ban on needle exchange.

The moral contradictions of the abstinence-mongers speak eloquently to the folly of basing public health decisions on religious injunctions and fantasies of social control. It's time for Congress to stop this dangerous crusade, both here and abroad.

An African Solution

Source: The Nation - http://www.thenation.com

posted May 24, 2007 (June 11, 2007 issue)

Andrew Rice

One afternoon in the fall of 2005, I was sitting at an outdoor cafe along a pleasant tree-lined street in Kampala, the capital of Uganda, flipping through the local newspaper, when the sight of an old friend's face stopped me cold. I'd lived in Uganda for two years in the early part of the decade, but I'd been gone for a while, and I'd been wondering what had become of him, an attorney in his 50s. I'd known him as an insightful and opinionated man. When we'd last met, many months before, we'd talked about his country's contentious democracy and his hopes for a new project he'd started, a legal fund to assist the victims of Uganda's past dictators. Now I saw my friend's distinguished face at the center of a black-bordered newspaper announcement, above a quote from Thomas Paine and the legend: "Loved and Remembered By Your Entire Family."

It had just started to rain, and Ali, my regular newspaper hawker, sat down at the table to wait out the storm beneath the cover of the cafe's awning. Ali had known the lawyer too. I pointed to the death notice. "Oh, yes, it was very sad," Ali said. "He was sick."

I understood what Ali was trying to tell me. In Uganda, you heard it all the time. When the foreign minister took ill and died, the local journalists whispered, "He was sick." When my neighbor, an economics professor, started acting strangely, hiring a witch doctor to make him potions, his nephew confided, "Uncle is sick." When my former housekeeper, a shy young born-again woman, began wasting away before my eyes, anyone could tell she was sick. I helped her buy medicine, but she was dead by Christmastime. The word "sick" is a euphemism Ugandans use when they want to say "AIDS." About 91,000 Ugandans died of the disease in 2005, the last year for which data are available, and estimates say a million people there are infected with HIV, the virus that causes it. In the United States, a country with ten times the population of Uganda, AIDS kills roughly one-sixth as many people each year.

As an American who grew up in the 1980s, I remember a time when this was supposed to be our future, not just Africa's. Back then, in the first years after AIDS burst out of the bathhouses of New York and San Francisco, a sense of terror gripped this country. Rock Hudson died, the Surgeon General issued grave warnings and a generation of gym teachers were issued dildos and condoms and pressed into service as safe-sex educators. Today those fears seem quaint, like the cold war-era films where students were instructed to take cover from nuclear attacks under their desks. Predictions that the disease would spread widely among heterosexuals in the United States have so far proved mercifully wrong. Antiretroviral drugs have turned HIV into a manageable--though still incurable--condition. More than fifteen years after announcing his HIV diagnosis, Magic Johnson is developing real estate and looks a lot healthier than Larry Bird.
For all our worrying, the "HIV rate in the United States never exceeded one percent," Helen Epstein writes in her new book, The Invisible Cure. "At first, some UN officials predicted that HIV would spread rapidly in the general population of Asia and eastern Europe, but the virus has been present in these regions for decades and such extensive spread has never occurred." Sub-Saharan Africa is a different story. In some countries there, well over 30 percent of adults younger than 50 are thought to be infected with HIV. To appreciate the scale of the epidemiological disaster, consider this: Heart disease, the leading cause of death in the United States, killed some 650,000 Americans in 2004. If AIDS had hit this country as hard as it has Zimbabwe or Botswana, 3-4 million Americans would be dying of AIDS every year.

This is an immense crisis, and the developed world, to its credit, has roused its conscience. Bono, Madonna and Oprah have lent their famous monomials to initiatives meant to halt the disease's spread and soothe its consequences. Warren Buffett and Bill Gates have pledged their fortunes to the search for a vaccine and other vital research. Bill Clinton has made the continent's AIDS epidemic a focus of his post-presidential philanthropy. President Bush, not to be outdone, has promised $15 billion to fight AIDS in Africa, an initiative that for all its many weaknesses does represent "the biggest international health intervention ever attempted," journalist Stephanie Nolen writes in her book 28: Stories of AIDS in Africa. Yet for all these worthy efforts, the disease kills an estimated 5,500 Africans a day. Though Africa is the poorest continent, and certainly the least healthy one, its uncommon vulnerability to AIDS can't simply be explained by lack of wealth or access to medicine. Indeed, one lesson a reader takes away from the two books under review is that the epidemic is egalitarian: It kills the children of African farmers, businessmen and presidents alike.

In 1987, at the most panicked juncture of America's AIDS epidemic, journalist Randy Shilts published And the Band Played On, the finest piece of journalism ever written about this--and maybe any--disease. To date, no book on the African epidemic has managed to capture it so masterfully. In part, that's because most of them have been written by outsiders who can scarcely aspire to understand a foreign continent the way Shilts, one of America's first openly gay reporters, knew Castro Street. But the early AIDS epidemic also lends itself to a very traditional kind of narrative: It's a detective story in which doctors, scientists and gay rights activists scramble to identify and stop a killer. In their books on Africa, Epstein and Nolen must describe a far murkier state of affairs. Their contribution is to ask: Why is AIDS so difficult to stop in Africa, and why is our society, the richest and most technologically sophisticated in the world, unable to save Africans as we have ourselves? The story makes grim reading; it's a mystery to which there may be no solution.

Over the years, many medical researchers have tried to solve this deadly conundrum. Some point to biology, some to behavior and some to just plain bad luck. The inquiry, however, has been hindered by the nature of the disease. "AIDS is not an event, or a series of them; it's a mirror held up to the cultures and societies we build," Nolen writes in her introduction. "The pandemic, and how we respond to it, forces us to confront the tricky issues of sex and drugs and inequity." Moreover, in Africa it has required the international public health community--a group that's largely European and American, and therefore white--to address the sexuality of black people, an issue fraught with racial and colonial overtones. Some African leaders, notably South Africa's President Thabo Mbeki, are so sensitive to seeing their people stereotyped as lustful savages that they've given a platform to fringe scientists who deny that AIDS is sexually transmitted. The public health community, on the other hand, sometimes overcompensates, policing unconventional thoughts about the disease's origin and spread with the vigor of Soviet-era commissars. Writers who run afoul of this orthodoxy risk vituperative attacks. This is why I suspect the great AIDS book yet to come will be written by an African, and will probably be a novel, perhaps a satirical one.

It takes a great deal of confidence to name a book about this disease The Invisible Cure. Luckily, Helen Epstein has a compelling thesis, and she explains it in lucid, sometimes extraordinary, prose. She has clearly benefited from a literary upbringing: Her parents, Barbara and Jason Epstein, were co-founders of The New York Review of Books, and several of her chapters first appeared as essays in that magazine. But she is also a molecular biologist, though seemingly a disillusioned one. With unstinting self-awareness, Epstein describes how, in the early 1990s, she went to Uganda to search for a "magic bullet," a scientific answer to the disease: an HIV vaccine. She was so enthusiastic that she paid her own way on the trip. "I felt like a pioneer," she writes. "The hour of the lone scientist following his or her imagination into the unlit corners of nature is passing." In the end, Epstein's imagination didn't lead her to a breakthrough, and her faith in scientific solutions waned. (In fact, HIV mutates so quickly that some experts now doubt whether it is even possible to engineer an effective vaccine.) But she did acquire a healthy skepticism for the pieties of humanitarian work as she toiled in labs alongside better-funded colleagues. "I was just a hitchhiker, and as hitchhikers sometimes do, I became a little arrogant," she writes. "Hitchhikers live cynical, parasitic existences, but sometimes they see the landscape more clearly than drivers."

The landscape of Uganda in the early 1990s was far different from the one I encountered a decade later. At the time Epstein arrived there, the country was recovering from two decades of tyranny and civil war, and people were dying of AIDS in numbers far greater than today. Uganda was the first country in Africa to feel the full force of the epidemic, which first emerged in the fishing villages ringing Lake Victoria in the late 1970s. (The origin of the virus, which probably crossed the species barrier from monkeys to humans less than a century ago, is another great mystery. Epstein speculates that it might have been inadvertently spread by colonial-era vaccination campaigns.) By the early 1990s, it was estimated that one-third of all adults in Kampala were HIV positive. The disease seemed to strike the very people a rebuilding society could least afford to lose: university students, their professors, lawyers, journalists and especially doctors.

"Then something remarkable occurred," Epstein writes. In the early '90s, unbeknownst to anyone else in Uganda at the time, the rate of HIV prevalence began to fall. At first, it seemed like a fluke. But Uganda's prevalence rate kept plummeting, from 30 percent to 20 percent to less than 10 percent, where it remains today. People called it a "miracle," and wondered what Ugandans were doing right, because elsewhere in Africa the virus was still spreading exponentially. Epstein had an idea, but she didn't yet recognize its significance. "Back then I was still subject to magic bullet thinking--the idea that serious public health problems could be addressed without considering their social and political causes," she writes. "The Ugandans seemed to know better, but their message was lost on me."

What was Uganda's secret? In public health circles, the argument continues to this day. There are basically three theories. One says the secret was in the statistics. The early estimates that 30 percent of the population had HIV may have been overstated, and the subsequent drop might be explained by the cold fact that infected people were dying. A second theory says the secret was on the billboards. In the 1990s, advertisements promoting condom brands called Lifeguard and Protector appeared all over the country, with the support of Uganda's youthful president, Yoweri Museveni, who urged his people to set aside the traditional value placed on having large families. The third theory says the secret was in the bedroom. It's commonly believed that Africans, many of whom come from cultures that practice polygamy, are relaxed about sexual mores and promiscuity, at least of the heterosexual variety. But the fear of AIDS, this theory suggests, forced them to change their behavior.

Epstein finds each of these explanations wanting. If the prevalence of HIV in Uganda was dropping just because deaths from AIDS were outpacing new infections, why hasn't this pattern repeated itself elsewhere in Africa? It's hard to measure condom use--in the average sexual encounter, only two people really know what happened--but anyway, Epstein writes, it appears Uganda's infection rate was falling before the marketing campaigns began. (And even with all the AIDS deaths, the country's population has almost doubled since 1990, which suggests that birth control has not exactly caught on.) As for the notion that Africans are more promiscuous, studies indicate that the average Ugandan has sex with fewer people over the course of a lifetime than the average American.

So something else was going on. "Because HIV prevalence in Africa is highest among heterosexual men and women, most people suspected it must have something to do with sex," Epstein writes. "But what were Africans doing differently?"

When it comes to African culture, there may be no word more charged than "polygamy." It brings to mind those titillated travelogues by Victorian explorers, with their descriptions of bare-breasted women and chiefs in leopard skins. But this is how polygamy usually works in contemporary Africa. I have a Ugandan friend--I'll call him David--whose father is a well-off merchant. When David was a young man, his father was often away from home on business trips. When he got a little older, David discovered that there was another reason for his father's absences: He'd taken up with a younger woman. David's mother knew, and she was furious, but there wasn't much she could do. Ugandan divorce laws are skewed against women, and she and her children depended on her husband's income. David's parents stayed together, and his father's second wife, and second life, was never mentioned around the house. When David reached adulthood, he decided he wanted to meet his half-siblings, and they cautiously got to know one another. But some tension remains between the two sides of the family over David's father's money and favor. It's a messy, emotionally difficult arrangement--one that might not seem entirely unfamiliar to many "blended" American families.

There is an important difference, though, and Epstein believes it explains Africa's exceptional susceptibility to AIDS. Americans tend to leave one relationship for the next. Ugandans--or, rather, Ugandan men--don't have to choose. Another way of describing this phenomenon is to say that Europeans and Americans typically have lovers consecutively, while Africans--men and women alike--are commonly involved in several overlapping relationships. Studies have found that such "concurrent or simultaneous sexual partnerships are far more dangerous than serial monogamy," Epstein writes, "because they link people up in a giant web of sexual relationships that creates ideal conditions for the rapid spread of HIV." In any given sexual encounter, an HIV-positive person has around a 1-in-100 chance of passing on the virus. That's a long shot in the context of a one-off tryst with a prostitute, but extended over the course of an enduring relationship, the chance of infection rises to near-certainty. Also, in many African cultures, men are not circumcised, which considerably increases their vulnerability. (Recent studies suggest this simple procedure cuts in half a man's risk of infection.) Epstein produces a series of charts that the reader can view like a flip book, showing how a single case of HIV can spread through a network of concurrent relationships in just a few months.

In the early years of the epidemic in Africa, much of the medical community's response was geared toward intervening with so-called high-risk groups: truckers who crisscrossed the continent; migrants who toiled in South African mines; the bar girls and prostitutes who serviced them. As the role of concurrency came to be understood, the true perversity of the epidemic revealed itself. In Africa, the biggest risk factor is trust.

Whatever the "invisible cure" might have been--and Epstein has an interesting hypothesis--it's fairly certain that Ugandans came up with it themselves. "It seemed to me that what mattered most was something for which public-health experts had no name," Epstein writes. "It is best described as a social movement characterized by a shared sense of humanity, collective action, and mutual aid that is impossible to quantify or measure." That sounds a bit nebulous, and the fuzziness points to a weakness in her book: It's better at analyzing societies than describing individuals. In a way, she's made an understandable authorial choice: The world doesn't need another book that caricatures helpless African victims. But social movements are made of people, of millions of solitary commitments born of personal experience and tragedy.

Stephanie Nolen's book shows how AIDS is affecting Africans in their everyday lives, and gives us some idea of the form Epstein's social movement might take. Nolen presents brief profiles of twenty-eight people, a number she chose because 28 million Africans are estimated to be living with HIV. A South Africa-based correspondent for the Toronto Globe and Mail, Nolen has traveled widely around the continent, interviewing everyone from Nelson Mandela to shantytown prostitutes. She is an evocative and empathetic writer, and her journalism doesn't succumb to the affliction of so much other writing about Africa, the tendency to reduce people to categories that fit the reader's, and the author's, preconceptions: corrupt or honest, victim or killer, sinner or saint. When Nolen rides shotgun with an HIV-positive long-haul trucker who claims to have bedded 100,000 women, she doesn't condemn him to her readers; she just lets him tell his tale.

The people introduced here give one a sense of the breadth of the epidemic. They're not exactly representative, though; a more descriptive title for Nolen's book might have been The Exceptions. All of the people she interviews meet two conditions: First, they're alive, and second, they're willing to talk frankly about AIDS, which in Africa is unusual. "Stigma is one of the most used words in the AIDS pandemic, a two-syllable shorthand for the shame and fear that cling to this disease," Nolen writes. There is "a particular distaste saved for those diseases where the sick are viewed as the authors of their own misfortune, and a particular shame that comes with a disease most often transmitted by sex."

Consequently, Nolen's profile subjects are largely a self-selected group. Many are HIV-positive people who have started advocacy groups, or who work for Western nongovernmental organizations. You get the feeling you might run into a couple of them crossing the lobby of the Nairobi Hilton the next time the UN holds an AIDS conference there. But Nolen is such a gifted writer that her book transcends its limitations. To read the stories of Malawi's Alice Kadzanja, a nurse who contracted HIV from her husband, a philandering college administrator; or Zimbabwe's Prisca Mhlolo, who lost her husband and her daughter and was shunned by her family because AIDS "was a disease for prostitutes"; or Uganda's Gideon Byamugisha, an Anglican priest who admits he "did some good things...and failed in some" in relating how he passed HIV on to his late wife, is to see Helen Epstein's thesis about concurrency brought to life. The book's finest moments, however, are the ones that take Nolen by surprise: An AIDS counselor she knows in Zambia tests positive; a little girl she met in Johannesburg dies. When her dreadlocked artist friend Thokozani, who's told her he always uses condoms, finds out he has the virus, she reflects:

At first I used to marvel at it--at why people have gone on making such choices in defiance of what might seem like the most basic survival instinct. But in talking to [Thokozani], I realized that it's not, in the end, so hard to understand. Infection rates are much higher here than in, say, Canada and France, but the variables that go into decisions about love and sex and intimacy, those are no different here. People have sex without condoms because it feels good to say you trust someone that much--or because there is a particular pleasure that comes in taking risks. Or, my friend points out, just because it feels nice. We all do things we know we shouldn't--especially when we're in love, or filled with lust, or lonely.

As it happens, Epstein believes that recognizing human nature was the key to Uganda's early success in bringing the HIV infection rate under control. She contrasts contemporary South Africa, with its culture of denial that extends up to the president, with Uganda in the early 1990s. Back then, every Ugandan was talking about AIDS: the president, newspaper columnists, taxicab drivers. People started support organizations, and churches got involved. The most successful program, Epstein argues, was a local initiative called Zero Grazing (Ugandans favor cattle metaphors). "Zero Grazing was a compromise," she writes, "and its real message was this: 'Try to stick to one partner, but if you have to keep your long-term mistresses, concubines and extra wives, at least avoid short-term casual encounters with bar girls and prostitutes.'"

At the same time, the AIDS crisis also galvanized Uganda's women's rights movement. In Africa, many women are stuck in "transactional" relationships with men, relying on their money and lacking power to demand faithfulness. In the early 1990s, "women were being urged to keep their daughters in school, start small businesses, and challenge laws and practices that discriminated against women," Epstein writes. The activists also used the Zero Grazing campaign as ammunition to confront men about their behavior: "In bars and discos that were once mobbed with men and single women, men now sat drinking among themselves." The number of people reporting casual sexual partners dropped. This "partner reduction" strategy worked, Epstein says, because such casual encounters served as "on-ramps" through which HIV entered concurrent-relationship networks.

If Zero Grazing was as successful as Epstein says, you'd think international organizations would have paid to reproduce the campaign all over the continent. But they didn't--for reasons that are once again more about our preconceptions than Africa's needs. On the one hand, Western conservatives couldn't stomach a program that countenanced polygamy. On the other--and Epstein doesn't explicitly make this connection--the early 1990s coincided with a huge homegrown evangelical revival in Uganda, and many of the loudest women's rights activists were also born-again Christians. This association made many Western liberals--the type who work for organizations like the UN--quite uncomfortable. "There was a sense that promoting fidelity must be totally wrong if it was a message favored by the Christian Right," the former head of one humanitarian group told Epstein.

Near the end of her book, Epstein notes with some sadness that Zero Grazing is now a museum piece. These days, Uganda's approach to AIDS is ruled by pieties--both religious and secular. The locally devised programs of fifteen years ago have been replaced by a bland package of somewhat conflicting strategies known by the acronym ABC: abstain, be faithful, use a condom. The Bush Administration and the evangelicals push A, the public health community stresses C and no one pays much attention to B, because there's no money in nuance. Meanwhile, on the strength of its "miracle," Uganda has become an AIDS pilgrimage spot. "The big hotels in the capital play host to a perpetual round of AIDS-related conferences and workshops, and the streets are jammed with the vehicles of AIDS NGOs," Epstein writes.

The influx of money has brought profiteers, both white and black. A recent investigation revealed massive corruption in the Ugandan Health Ministry's administration of grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria. That's just the beginning of the graft. And yet for all the many millions flowing in, HIV prevalence rates have not fallen much since the year 2000. Men aren't sitting alone at bars anymore, and statistics suggest that casual sex may once again be on the rise. For a fleeting moment, in a time of unimaginable tragedy, Ugandans found it within themselves to fight this epidemic. But AIDS has a way outlasting vigilance. It's a disease of human fallibility, and for that there is no cure.

FDA Approves First Oral Fluid Based Rapid HIV Test Kit

Source: http://www.fda.gov/bbs/topics/news/2004/NEW01042.html

March 26, 2004

FDA today approved the use of oral fluid samples with a rapid HIV diagnostic test kit that provides screening results with over 99 percent accuracy in as little as 20 minutes. Until now, all rapid HIV tests required the use of blood in order to get such rapid results.

The original version of this rapid test -- the OraQuick Rapid HIV-1/2 Antibody Test, manufactured by OraSure Technologies, Inc., Bethlehem , Pa. -- was approved November 7, 2002 for detection of antibody to HIV-1 in blood. On March 19, 2004 , FDA approved the test for detection of HIV-2 (a variant of HIV that is prevalent in parts of Africa but rarely found in the United States ) in blood. Today's approval represents another significant new use for the test. As when used on blood, this test can quickly and reliably detect antibodies to HIV-1 and can be stored at room temperature and requires no specialized equipment.

"Before the approval of this rapid test in November, 2002, many people being tested for HIV in public clinics did not return for the results of standard tests," said HHS Secretary Tommy G. Thompson. "Where the rapid test is available, those tested get their results within minutes. This oral test provides another important option for people who might be afraid of a blood test. It will improve care for these people and improve the public health as well."

To perform the test, the person being tested for HIV-1 takes the device, which has an exposed absorbent pad at one end, and places the pad above the teeth and against the outer gum. The person then gently swabs completely around the outer gums, both upper and lower, one time around. The tester then takes the device and inserts it into a vial containing a solution. In as little as 20 minutes, the test device will indicate if HIV-1 antibodies are present in the solution by displaying two reddish-purple lines in a small window on the device.

Although the results of rapid screenings will be reported in point-of-care settings, as with all screening tests for HIV, if the OraQuick test gives a reactive test result, that result must be confirmed with an additional more specific test. The OraQuick test has not been approved to screen blood donors. Although the test is approved to detect antibodies to HIV-1 and –2 when used on blood, today’s approval of the test for use on oral fluid is limited to detection of antibodies to HIV-1.

The OraQuick Rapid HIV-1/2 Antibody test for use on blood was categorized as a waived test under CLIA (Clinical Laboratory Improvements Amendments of 1988) in January, 2003. A waived test system can be given in facilities with any CLIA certificate, rather than only in facilities certified for higher complexity tests. As such, a test categorized as a waived test can be used in many more health care settings by many different health providers.
All new test systems are categorized as high complexity systems until they are submitted for categorization under CLIA.

"I strongly urge the OraSure company to apply for a CLIA waiver for this test using oral fluid samples as well," said Acting FDA Commissioner Lester M. Crawford, D.V.M., Ph.D. "If the FDA finds that the company’s data proves that the OraQuick test used with oral fluids is both easy and safe to use in the waived lab setting - as it is with used with blood - then more people will likely be tested for HIV infection. In addition, any risk to healthcare workers of performing the test will be greatly reduced since they will not be exposed to blood."

The Centers for Disease Control and Prevention (CDC) has estimated that one fourth of the approximately 900,000 HIV-infected people in the U.S. are not aware that they are infected. Because of the potential public health benefits of rapid HIV testing, the CDC and the Centers for Medicare and Medicaid Services (CMS) have worked with state and other health officials to make the test widely available and to offer technical assistance and training for its use.

Niger's Religious Leaders Form Alliance To Prevent Spread Of HIV

Source: http://www.medicalnewstoday.com

Article Date: 10 Aug 2007 - 18:00 PDT

Catholic, Muslim and Protestant religious leaders in Niger have formed an alliance to teach youth in the country about HIV/AIDS, Reuters reports. The alliance aims to help the government fight the spread of the virus by promoting HIV tests and through better integration of HIV-positive people into society.

According to Reuters, 95% of Niger's population is Muslim, and Islamic leaders have a large influence over the country's population. Religious Affairs Minister Labo Issaka said that religious groups are "ideally placed to influence people's values and behavior" because of "their impact on communities and households, and the way they are organized and present on the ground."

According to Reuters, about half of Niger's population is under age 15. About 1% of the population ages 15 to 49 is HIV-positive, according to United Nations estimates. Although Niger's HIV prevalence is low in comparison to many other sub-Saharan African countries, the country's population is growing rapidly, which could lead to an increase in HIV cases, and government officials have pledged not to be complacent.

Earlier this summer, government officials set up 40 medical centers in the country's capital, Niamey, where people can receive no-cost HIV tests. About 9,000 young people came forward to be tested, but authorities had anticipated 22,000, according to Reuters. HIV/AIDS prevention education is difficult in Niger because less than half of children attend school, and eight in 10 adults are illiterate, Reuters reports (Massalatchi, Reuters, 8/6).

 
AddMe - Search Engine Optimization
Changing LINKS
Changing LINKS